ScreenerHero

OCEA Ocean Biomedical Inc. Common Stock

Partial data
NAS · US · Healthcare · Biotechnology · oceanbiomedical.com
0.0010USD0.00%Mkt Cap: 232365 $P/E: —

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidat…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap232.37K USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.48M USD
Revenue/Share—
Last Price0.0010 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.91
EPS (Forward)-0.89
52W Range
0.000014% of range0.0072
52W High0.0072 USD
52W Low0.0000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE9.71%
ROA-1051.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.18M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-2300.10%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.17
Current Ratio0.06
Quick Ratio—
Book Value/Sh-0.56 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.232.37M
Float208.41M
Insiders10.31%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float2.05%
Short % Out.1.77%
Shares Short2.93M
Short (prev mo.)5.72M
Technical
SMA 500.0008 (+22.0%)
SMA 2000.0006 (+65.3%)
Beta0.31
S&P 52W Chg15.96%
Avg Vol (30d)116.27K
Avg Vol (10d)60.59K
Technical Indicators
RSI (14)51.6
MACD0.0001
MACD Signal0.0001
MACD Hist.-0.0001
BB Upper0.0019 USD
BB Middle0.0010 USD
BB Lower0.0002 USD
BB Width161.19%
ATR (14)0.0009 USD
Vol Ratio (20d)0.01x